OTC · IMVIF
IMV Inc.
$0.00$0.00 (0.0%)
IMV Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
Loading market information…
OTC · ALNAQ · USD
Stock price, earnings
Quote as of Dec 11, 2023, 07:47 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Allena Pharmaceuticals, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Operating as a biopharmaceutical firm, Allena Pharmaceuticals, Inc. focuses on unearthing, developing, and marketing oral enzyme therapies. These treatments are devised to assist patients in the United States afflicted by uncommon and serious metabolic as well as renal conditions. Central to its pipeline is ALLN-346, an innovative enzyme designed to degrade urate, targeting hyperuricemia and gout in individuals with advanced chronic kidney disease. The company, which commenced operations in 2011 and has its main office in Newton, Massachusetts, made headlines on September 2, 2022, by seeking voluntary reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:59 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q3 2020 |
|---|
| Nov 9, 2020 |
| -$0.22-4.76% vs estimate |
| $0.00 |
THE ANALYST VIEW
4 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
IMV Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00+$0.00 (+40,113.65%)
Indie Ranch Media, Inc.: Healthcare · Medical - Care Facilities.
$0.00$0.00 (0.0%)
TGC Ventures International, Inc.: Healthcare · Medical - Distribution.
$59.00-$0.23 (-0.39%)
Taisho Pharmaceutical Holdings Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 1.67% below the high.
$0.00$0.00 (0.0%)
Photoelectron Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
ReGen Biologics Inc.: Healthcare · Medical - Instruments & Supplies.
$0.00$0.00 (0.0%)
Green Hygienics Holdings Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00-$0.00 (-90.0%)
LifeHOUSE Holdings, LLC’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
